INTEGRA THERAPEUTICS
Biotech company designing next-generation gene-writing tools to cure genetic diseases
Biotechnology company that creates next-generation genetic writing tools to make advanced therapies safer, more effective and enable the integration of large amounts of information.
CEO: Avencia Sánchez-Mejías.
INVESTED COMPANY
2022
Details
Dr. Aiguader, 88
Barcelona Biomedical Research Park
08003 Barcelona (Spain)